Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast Cancer. [electronic resource]
- Scientific reports Jan 2020
- 1288 p. digital
Publication Type: Clinical Trial; Journal Article
2045-2322
10.1038/s41598-020-58339-2 doi
Adult Aged Aged, 80 and over Breast Neoplasms--blood Denosumab--administration & dosage Female Gene Expression Regulation, Neoplastic--drug effects Humans Middle Aged Neoplasm Metastasis Neoplasm Proteins--blood Neoplastic Cells, Circulating--metabolism Pilot Projects RANK Ligand--blood